Skip to content
10-K/A

Annual Report

UroGen Pharma Ltd. URGN

0001437749-25-013839

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 23, 2025 46.11M sh